En Es
Products
Covid-19
Companies
Pre-Owned
News
Events
About Us       Join now!
Categories

Browse Products by Category

Critical Care

Emergency Medicine

Intensive Care

Respiratory Care

Anesthesiology Systems

Home Care

Rehabilitation

Other

Hospital Infrastructure

IT Equipment

Transportation Systems

Other

Medical Imaging

Computed Tomography

Digital Radiography

Image Management Systems

Interventional Radiology

Magnetic Resonance Imaging

Mammography

PACS/RIS

Positron Emission Tomography

Radiation Safety

Radiography

Single-Photon Emission Computed Tomography

Ultrasound

Other

Patient Care

Bariatric Care

Beds

Examination Equipment

Other

Surgery

Endoscopy

Laparoscopy

Laser Surgery

Operating Room Equipment

Sterilization

Surgical Implants

Surgical Instruments

Waste Management

Other

Clinical Laboratory

Blood/Gas Analyzers

Cell Counters

Centrifuges

Clinical Chemistry Analyzer

Coagulation Analyzers

General Lab

Hematology Analyzers

Immunoassay Systems

Lab Glassware

Microplate Reader

Microscopes

Pipettes

Rapid Tests

Ready-to-use Kits for Analysis

Urine Analyzer

Other

Browse Products by Category

Close

Illumina

Illumina develops, manufactures and markets integrated systems for the analysis of genetic variations and biological functions. The company also provides sequencing and array-based solutions for genetic analysis, as well as genotyping, NIPT and whole-genome sequencing services for government laboratories, hospitals, an ...
Products Covid-19NewsSummary
Close

Covid-19 Illumina

Clinical Laboratory

SARS-CoV-2 NGS Test
Illumina COVIDSeq Test

The Illumina COVIDSeq Test is a high-throughput, next-generation sequencing test is intended for the detection of SARS-CoV-2 virus RNA in authorized countries and virus genome analysis for research use. This amplicon-based NGS test includes 2019-nCoV primers designed to detect RNA from the SARS-CoV-2 virus in nasopharyngeal, oropharyngeal, and mid-turbinate nasal swabs from patients with signs and symptoms of infection who are suspected of COVID-19.
More details

SARS-CoV-2 (COVID-19) Test
Illumina COVIDSeq Test

The Illumina COVIDSeq Test is the first NGS test approved for use under the US Food and Drug Administration’s Emergency Use Authorization (EUA). This amplicon-based NGS test includes 2019-nCoV primers designed to detect RNA from the SARS-CoV-2 virus in nasopharyngeal, oropharyngeal, and mid-turbinate nasal swabs from patients with signs and symptoms of infection who are suspected of COVID-19. The test can be run on the Illumina NovaSeq 6000 Sequencing System, NextSeq 500 Sequencing System, NextSeq 550 Sequencing System, or NextSeq 550Dx Instrument.
More details
Close

News of Illumina

Illumina and Boehringer Ingelheim Partner to Develop Companion Diagnostics (CDx) for Cancer Treatment

20 Jan 2022
Illumina and Boehringer Ingelheim Partner to Develop Companion Diagnostics (CDx) for Cancer Treatment
Illumina Inc. (San Diego, CA, USA) has entered into a partnership with Boehringer Ingelheim (Ingelheim am Rhein, Germany; www.boehringer-ingelheim.com) to develop companion diagnostics (CDx) for several programs in the latter’s oncology pipeline. The partnership aims to accelerate the development of therapy selection and precision medicines for patients with advanced cancer.
Read More

Illumina Acquires GRAIL to Accelerate Patient Access to Life-Saving Multi-Cancer Early-Detection Test

20 Aug 2021
Illumina Acquires GRAIL to Accelerate Patient Access to Life-Saving Multi-Cancer Early-Detection Test
Illumina, Inc. (San Diego, CA, USA) has acquired GRAIL (Menlo Park, CA, USA), a healthcare company focused on life-saving early detection of multiple cancers.
Read More
Close

About Illumina

Illumina develops, manufactures and markets integrated systems for the analysis of genetic variations and biological functions. The company also provides sequencing and array-based solutions for genetic analysis, as well as genotyping, NIPT and whole-genome sequencing services for government laboratories, hospitals, and reference laboratories, among others.
FaceBook Twitter Google+ Linked in
Sequencing System

Sequencing System

Model: NovaSeq 6000 Sequencing System
Request Information

Description:

The NovaSeq 6000 Sequencing System performs whole-genome sequencing more efficiently and cost-effectively than ever. Its scalable output generates up to 6 Tb and 20 billion reads in dual flow cell mode with simple streamlined automated workflows. The system can be configured to sequence a trio in one day or up to 48 genomes in ~2 days for the most comprehensive coverage.

Tags: [Clinical Laboratory], [General Lab]
Features Specifications

Features

• Scalable throughput for studies of all sizes
• Broad, deep sequencing for bigger discoveries
• Flexible performance for mix and match options
• Streamlined operations for increased efficiency Request Information

Specifications

Instrument configuration
• Computer and touch screen display
• Installation setup and accessories
• Data collection and analysis software

Instrument control computer
• Base Unit: Portwell WADE-8022 with Intel i7 4700EQ CPU
• Memory: 2 × 8 GB DDR3L SODIMM
• Hard Drive: None
• Solid-State Drive: 256 GB mSATA
• Operating System: Windows 10
Note: Computer configurations will be upgraded regularly; contact your local account manager for current configuration

Operating environment
• Temperature: 19°C-25°C (22°C ±3°C), Request Information

Send A Message To This Supplier

* Required Information
* Email
To
Illumina (Sequencing System)
* Message

More Products From This Supplier

NGS Test
MiSeqDx Cystic Fibrosis 139-Variant Assay
SARS-CoV-2 NGS Test
Illumina COVIDSeq Test
NGS System
iSeq 100 System
Clinical NGS System
MiSeqDx System
NGS System
NextSeq 550Dx
Benchtop Sequencer
MiniSeq System
SARS-CoV-2 (COVID-19) Test
Illumina COVIDSeq Test
NGS System
NextSeq 2000
Copyright © 2000-2022 TradeMed.com. All rights reserved. | Terms And Conditions